Biogen Inc (BIIB) Insider Trading
- $186,025,247.73
- $136,775,292.44
- Sept. 3, 2024
- George A Scangos
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
June 1, 2016 | CEO | 3,855 | $289.74 | Sell | $1,116,947.70 | |
May 25, 2016 | CEO | 157 | $280.00 | Sell | $43,960.00 | |
May 2, 2016 | CEO | 487 | $274.74 | Sell | $133,798.38 | |
April 6, 2016 | CEO | 157 | $280.00 | Sell | $43,960.00 | |
April 6, 2016 | EVP | 102 | $275.00 | Sell | $28,050.00 | |
April 1, 2016 | CEO | 487 | $258.83 | Sell | $126,050.21 | |
March 1, 2016 | CEO | 487 | $261.37 | Sell | $127,287.19 | |
Feb. 25, 2016 | CMO | 183 | $261.90 | Sell | $47,927.70 | |
Feb. 25, 2016 | EVP | 84 | $261.90 | Sell | $21,999.60 | |
Feb. 17, 2016 | Chief Medical Officer | 722 | $256.16 | Sell | $184,947.52 | |
Feb. 17, 2016 | CEO | 487 | $256.16 | Sell | $124,749.92 | |
Feb. 9, 2016 | Chief Medical Officer | 852 | $246.54 | Sell | $210,052.08 | |
Dec. 4, 2015 | CMO | 441 | $277.00 | Sell | $122,157.00 | |
Oct. 23, 2015 | Director | 310,000 | $277.47 | Buy | $86,015,700.00 | |
July 27, 2015 | Director | 10,000 | $304.88 | Buy | $3,048,800.00 | |
June 19, 2015 | EVP | 3,841 | $410.00 | Sell | $1,574,810.00 | |
June 1, 2015 | CEO | 1,362 | $398.87 | Sell | $543,260.94 | |
April 1, 2015 | CEO | 1,362 | $423.20 | Sell | $576,398.40 | |
March 25, 2015 | EVP | 12,010 | $449.06 | Sell | $5,393,210.60 | |
March 20, 2015 | Director | 11,667 | $475.00 | Sell | $5,541,825.00 | |
March 19, 2015 | Director | 2,333 | $436.14 | Sell | $1,017,514.62 | |
March 17, 2015 | Director | 4,667 | $425.45 | Sell | $1,985,575.15 | |
March 10, 2015 | Director | 3,625 | $413.40 | Sell | $1,498,575.00 | |
March 2, 2015 | SVP | 3,174 | $409.49 | Sell | $1,299,721.26 | |
Feb. 17, 2015 | EVP | 2,128 | $389.11 | Sell | $828,026.08 | |
Feb. 10, 2015 | SVP | 1,143 | $398.11 | Sell | $455,039.73 | |
Feb. 2, 2015 | EVP | 1,656 | $389.03 | Sell | $644,233.68 | |
Dec. 15, 2014 | SVP | 1,981 | $346.50 | Sell | $686,416.50 | |
Dec. 2, 2014 | EVP | 1,749 | $335.65 | Sell | $587,051.85 | |
Nov. 11, 2014 | EVP | 1,750 | $330.00 | Sell | $577,500.00 | |
Nov. 3, 2014 | CEO | 1,128 | $320.78 | Sell | $361,839.84 | |
Oct. 1, 2014 | CEO | 1,127 | $330.97 | Sell | $373,003.19 | |
Oct. 1, 2014 | EVP | 1,750 | $330.97 | Sell | $579,197.50 | |
Aug. 1, 2014 | CEO | 1,128 | $332.93 | Sell | $375,545.04 | |
July 16, 2014 | CEO | 12,316 | $312.37 | Sell | $3,847,148.92 | |
May 19, 2014 | EVP | 1,221 | $289.15 | Sell | $353,052.15 | |
May 1, 2014 | CEO | 2,123 | $285.56 | Sell | $606,243.88 | |
April 17, 2014 | EVP | 1,221 | $291.00 | Sell | $355,311.00 | |
April 1, 2014 | CEO | 2,123 | $308.42 | Sell | $654,775.66 | |
April 1, 2014 | Director | 6,250 | $308.42 | Sell | $1,927,625.00 | |
March 31, 2014 | Director | 3,000 | $296.76 | Sell | $890,280.00 | |
March 20, 2014 | Director | 10,000 | $348.88 | Sell | $3,488,800.00 | |
March 19, 2014 | EVP | 3,505 | $352.29 | Sell | $1,234,776.45 | |
March 17, 2014 | EVP | 1,221 | $334.83 | Sell | $408,827.43 | |
March 11, 2014 | EVP | 8,428 | $336.83 | Sell | $2,838,803.24 | |
March 3, 2014 | CEO | 2,942 | $335.79 | Sell | $987,894.18 | |
Feb. 26, 2014 | SVP | 1,048 | $342.17 | Sell | $358,594.16 | |
Feb. 18, 2014 | EVP | 1,222 | $327.90 | Sell | $400,693.80 | |
Feb. 13, 2014 | EVP | 1,290 | $316.81 | Sell | $408,684.90 | |
Feb. 11, 2014 | SVP | 2,085 | $314.31 | Sell | $655,336.35 |
Insiders are both buying and selling Biogen Inc stock.
The insider traders at Biogen Inc are: George A Scangos, Alfred Sandrock, Priya Singhal, Alexander J Denner, Michel Vounatsos, George Scangos, Robert W Pangia, Steven Holtzman, Eric K Rowinsky, Brian S Posner, Steven H Holtzman, Lynn Schenk, Kenneth Dipietro, Adriana Karaboutis, Susan H Alexander, Adam Koppel, Caroline Dorsa, Douglas Williams, Paul Clancy, Paul J Clancy, Raymond Pawlicki, Robert Pangia, Stephen A Sherwin, Stuart Kingsley, Alexander J. Denner, Eric Rowinsky, Spyridon Artavanis-Tsakonas, Stelios Papadopoulos, William Young, Michael D Ehlers, John Cox, Douglas E Williams, Brian Posner, and Ginger Gregory
The most active insider trader at Biogen Inc is George A Scangos with 19 trades.
Paul Clancy has sold the most Biogen Inc stock with a total value of $36,720,528.10.
Alexander J Denner has bought the most Biogen Inc stock with a total value of $186,501,152.46.
The most recent insider trade for Biogen Inc was on Sept. 3, 2024.
The single biggest insider buy for Biogen Inc was from Alexander J Denner with a total value of $86,015,700.00 on Oct. 23, 2015.
The single biggest insider sell for Biogen Inc was from Paul Clancy with a total value of $23,595,878.10 on Sept. 16, 2013.